protein, whose basic region is weakly helical (4). The We have established an expression system for full-NMR structure of HIV-1 Tat exhibits a well defined hylength HIV-1 transactivator (Tat) protein in Esche-drophobic core and a similarly well defined glutamine richia coli. By constructing a synthetic gene for high rich domain which sandwich the N-terminal residues level expression in enteric bacteria, the recombinant from Val4 to Pro14. The cysteine rich and the basic region protein can be obtained in high yield. Fusion of the are highly flexible, and the basic region shows no obvious Tat sequence to an N-terminal histidine tag allows the helical tendency. The Arg-Gly-Asp (RGD) loop of the Crapid purification of the fusion protein through a sin-terminal region is structured as a rigid solvent exposed gle chromatographic step. After cleavage of the fusion hairpin (5). Tat is unique among transcriptional activaprotein with CNBr, pure Tat can be obtained through tors as its cis-regulatory target is an RNA element (transthe use of a MonoS column. Reduction of the protein activation response element, TAR). TAR is located just with Tris(2-carboxyethyl)phosphine-HCl and subse-downstream of the long terminal repeat (LTR) promoter quent stepwise refolding yields biologically active Tat. (6) and forms a hairpin structure that spans nucleotides Sample purity and the identity of the protein mass /1 to /59 of all transcripts. The minimal functional TAR with the mass expected from the amino acid sequence sequence (/19 to /42) includes the upper stem, a uracilwas demonstrated by mass spectrometry. Nuclear rich trinucleotide bulge, and a structured hexanucleotide 
binding coactivator (8) . Whereas in the absence of Tat Ç90% of the transcripts terminate around position /59, in the presence of Tat more than 99% of the transcripts are of full length. The Tat protein thus functions as a Human immunodeficiency virus type 1 (HIV-1) transactivator (Tat) protein (1, 2) upregulates viral production transcriptional anti-terminator (6) .
It has been shown that mice transgene for tat develop by three orders of magnitude (3) . The tat gene consists of two exons, the first coding for 72 residues, the second dermal lesions resembling Kaposi's sarcoma (9) which in an aggressive form is frequently associated with HIVcoding for an additional 10 to 29 residues. Tat can be divided into five distinct sequence domains: the N-termi-1 infection. Further studies confirmed that Tat is released by infected human cells and in synergy with basic nal acidic, cysteine-rich, core, basic, and C-terminal glutamine-rich sequences. The structure of the Tat protein fibroblast growth factor induces Kaposi's sarcoma (10).
Tat proteins are considered a major target for antivifrom equine infectious anemia virus (EIAV) has been determined bei two-dimensional NMR spectroscopy and ral therapies. Thus, determining the three-dimensional structure of this protein and its various protein and shows, except for a rigid core region, a highly flexible RNA complexes is of utmost importance. So far, spec-min and cooled to room temperature in 5 h. The parallel annealing reactions were pooled and adjusted to 100 ml troscopic studies on Tat proteins employed either non-HIV proteins such as the equine infectious anemia vi-with 10 mM ATP and 10 units of T4 ligase (USB). Ligation was performed for 16 h at 14ЊC. The tat gene was purified rus Tat protein (4, 11) , chemically synthesized HIV-1 Tat protein (5), or peptide analogs (12-14). For more by 1.5% agarose gel electrophoresis, excised and subsequently purified with a QIAquick kit (QUIAGEN, Hilden). extensive studies demanding high amounts of protein, and eventually isotopic labeling of the protein for nuclear magnetic resonance spectroscopy, it is highly de-Cloning of the Synthetic Gene sirable to employ bacterially produced protein from a
The tat gene was ligated with agarose gel-purified high yield expression and purification system.
NdeI/EspI-cut pET16b (Novagen, Madison, WI). This The preparation of Tat protein has been hampered ligation mixture was used to transform 200-ml portions by its high cysteine content and its susceptibility to of E. coli strain DH5a cells, made competent by the oxidation leading to the formation of stable multimers standard CaCl 2 method. Ampicillin-resistant clones (15). Some reports on the preparation of recombinant were picked and grown overnight in LB medium/ampiTat restrict on first exon Tat (16,17), lacking the RGD cillin. Plasmid DNA was prepared and restricted with sequence that is coded by the second exon. A model for
SacII and MluI to screen for recombinant plasmids. the cellular adhesion of Tat employs the binding of Tat
The recombinant plasmid was termed pTK1 and seto integrins via this sequence (18), resulting in cellular quenced by the alkali-denatured plasmid chain-termiuptake of the protein and transformation of endothelial nation method using T7 promoter and terminator primcells to Karposi's sarcoma cells (19) . Other purification ers and T7 DNA polymerase (Pharmacia, Freiburg). protocols give only relatively low yields (20) . We report pTK1 was transformed into Escherichia coli cells of high-yield purification of biologically active full-length strain BL21(DE3) plysS for expression. Tat protein from a synthetic gene. Additionally, we show that the prepared protein is suitable for further Expression structural investigations by two-and multidimensional NMR spectroscopy which should improve our knowlFermentation of E. coli BL21(DE3) plysS pTK1 was edge of the atomic details of Tat action.
performed at 37ЊC in a 7-liter working volume of LB medium containing ampicillin at 50 mg/liter and chlor-
MATERIALS AND METHODS
amphenicol at 34 mg/liter. The medium was inoculated with 150 ml overnight culture. The culture was aerated Chemicals with 3 liters/min and stirred with 300 rpm until the OD 600 Unless otherwise indicated, chemicals were obtained reached 0.3. Above OD 600 0.3 the aeration was increased from Merck (Darmstadt).
to 7 liters/min and the stirring to 700 rpm. When the OD 600 reached 0.8 to 1.0 Tat expression was induced with isopropyl-b-D-thiogalactopyranoside (IPTG) to a final Construction of the Tat Expression System concentration of 3 mM. Following induction, cells were The Tat amino acid sequence was HIV-1 Zaire 2 grown for 4 h, harvested by centrifugation at 6000 rpm (H1Z2) except that an extra leucine residue was intro-for 15 min at 4ЊC and stored at 020ЊC until needed. duced after Met1, as Met1 is removed during preparaTo test whether Tat was expressed in minimal medium tion. A synthetic gene was designed based on the fol-with 20 mM glucose, 100 ml medium supplemented with lowing considerations: First, codon usage was adapted 50 mg/liter ampicillin and 34 mg/liter chloramphenicol to that for highly expressed genes of enteric bacteria. were inoculated with 4 ml overnight culture of E. coli Second, it was attempted to minimize mRNA secondary BL21 (DE3) plysS pTK1 and incubated at 37ЊC. At an structure formation. The gene was divided into four OD 600 of 1.0 a sample of noninduced cells was taken and building blocks (Fig. 1) . The commercially obtained oli-the expression of Tat was induced by adding IPTG to a gonucleotides (MWG, Mü nchen) differed in length from final concentration of 1 mM. Samples were taken after 30, 57 to 74 nucleotides with overlaps between 8 and 12 90, and 150 min. Cells were pelleted by brief centrifuganucleotides to enhance ligation efficiency.
tion, 50 ml Laemmli buffer was added, and the cell suspenPortions (1 nmol) of the oligonucleotides (except Hi1 sion was heated to 95ЊC for 10 min. Aliquots of 10 ml were and Hic4) were phosphorylated with 10 nmol ATP and analyzed by denaturating gel electrophoresis. 10 units of T4 polynucleotide kinase (USB, Cleveland, OH) in 19 ml of kinase buffer for 45 min at 37ЊC. The Protein Purification reaction was stopped by heating to 65ЊC for 45 min. For hybridization, 200 pmol of complementary oligonucleoAll purification steps were carried out at room temperature, unless otherwise specified. Frozen cells were tides in 20 ml ligase buffer were heated to 90ЊC for 5 suspended in 4 ml/g wet cell weight buffer A (6 M urea, was removed by two centrifugation steps: first at 16,500 rpm, 4ЊC, for 30 min, and second at 40,000 rpm, 20 mM Tris-HCl, pH 8.0, 500 mM NaCl, 5 mM imidazole) and stirred for 48 h at 4ЊC. Insoluble cell debris 4ЊC, for 30 min. The supernatant was sterile filtered were collected, pooled, and lyophilized.
The lyophilized protein was dissolved in 70% (v/v) formic acid, and solid CNBr was added to a final concentration of 20% (w/v). The cleavage reaction was al-(diameter 0.2 mm) and applied to a 25 ml chelating lowed to proceed for 24 h in the dark under vigorous Sepharose column (Pharmacia) loaded with 100 ml 50 shaking. The mixture was lyophilized to remove remM NiSO 4 and preequilibrated with buffer A. The col-maining CNBr and volatile cleavage products, redisumn was washed with four column volumes of buffer solved in 100 mM NaOAc, pH 5.0, 200 mM NaCl (buffer A and eight volumes of buffer A with 150 mM imidazole. B), and loaded on a MonoS HR 5/5 column (Pharmacia) The fusion protein was eluted with two column volumes preequilibrated in buffer B. A gradient from 200 mM of buffer A with 1 M imidazole. Tat containing fractions to 1.5 M NaCl in the same buffer was applied. Recombiwere pooled and the pH was adjusted to 7.0 by adding nant Tat protein eluted in fractions containing 1.045 1 M HCl. Then the solution was dialyzed against 5 liters M NaCl. Elution fractions were pooled and lyophilized.
Reduction of Disulfide Bonds and Refolding
The lyophilisate was dissolved in 6 M urea, 1 mM KH 2 PO 4 /K 2 HPO 4 , pH 6.0, 2 mM NaCl, and solid Tris(2-carboxyethyl)phosphine-HCl (TCEP-HCl) was added to get a final molar ratio of TCEP-HCl to Tat of 25 to 1. Reduction of disulfide bonds was carried out at room temperature in the dark for 8 h.
Then, the mixture was dialyzed for 12 h each against:
( Activity assays. A reporter construct containing the electrophoresis of 10-ml aliquots on discontinuous 20% P. pyralis luciferase gene under the control of the HIVpolyacrylamide-SDS gels was performed with water 1 NL4-3 LTR was kindly provided by Dr. Georg Sczacooling to avoid temperature gradients and a constant kiel (Heidelberg). The plasmid was transfected into current of 20 mA according to Laemmli (18) with a HeLa cells grown in Dulbecco's modified Eagle's meHoefer, Inc., MightySmall vertical gel system. The dium (DMEM) with 10% FCS in 60-mm dishes by the samples were heated with 10 ml sample buffer (40% DEAE-dextran method (24) . Twenty-four hours after (w/v) sucrose, 3% (w/v) SDS, 3% (v/v) 2-mercaptoetha-transfection cells were washed with phosphate-bufnol, 0.075% (w/v) bromphenol blue) at 95ЊC for 5 min. fered saline (PBS), and fresh medium containing 200 After 1 h electrophoresis the gels were stained with nM of purified Tat protein in a final volume of 3 ml was staining solution (0.05% (w/v) Coomassie brilliant blue added. Chloroquine (100 mM) was included to enhance G-250, 45% (v/v) methanol, 9.2% (v/v) acetic acid) and transactivation. Luciferase activity was measured 24 destained with destaining solution (26% (v/v) metha-h later using the Promega Luciferase Assay System nol, 1% (v/v) acetic acid) twice for 30 min. Gels were (Serva, Heidelberg) and a Berthold Lumat (Berthold, documented with the Cybertech CS-1 Image Documen-Bad Wildbad) according to the manufacturers instructation System (Cybertech, Berlin).
tions.
MALDI-MS.
A trace amount of protein was dissolved in H 2 O and subjected to matrix-assisted laser RESULTS AND DISCUSSION desorption -time of flight (MALDI -TOF) mass specFermentation trometric analysis on a Shimadzu Kompact MALDI II mass spectrometer with sinapinic acid as matrix.
The fermentation of the expression strain E. coli N-terminal sequencing. Lyophilized Tat-fusion BL21(DE3) plysS pTK1 in 7 liters LB medium suppleprotein (500 pmol) was dissolved in 10 ml 0.1% (v/v) mented with 50 mg/liter ampicillin and 34 mg/liter trifluoroacetic acid and spotted on a Polybrene-chloramphenicol and inoculated with 150 ml overnight coated glass filter disc for sequence analysis. Se-culture resulted in rapid growth to an OD 600 0.8 within quencing of the first 30 amino acid residues was done 2.5-3 h. After induction with IPTG, the culture grew on a Model 476A sequencer (Applied Biosystems, to an OD 600 2.8-3.5 within 3 additional h. Cells were Foster City, CA).
harvested after 3 h because there was no further increase in cell growth and Tat expression reached a pla-1 H-NMR spectroscopy. Lyophilized protein was dissolved in 90% H 2 O/10% (v/v) D 2 O to yield a final concen-teau (data not shown). We obtained reproducibly about 21-24 g of whole cells with our 7-liter fermentor detration of 1.2 mM. Concentrations of KH 2 PO 4 /K 2 HPO 4 and NaCl were 10 and 20 mM, respectively. The pH sign.
The test for expression of Tat in minimal medium was 6.3. Spectra were recorded on a Bruker AMX600 spectrometer at 298 K.
with glucose as sole carbon source was positive (Fig. FIG. 4 . MALDI-MS spectra of fusion protein (a) and Tat (b). The matrix was sinapinic acid and spectra were recorded on a Shimadzu Kompact MALDI II mass spectrometer. The peak with half mass/charge ratio represents the double charged protein.
2). After 90 min a band on the SDS -PAGE gel repre-beled Tat protein will faciliate the interpretation of Tat -TAR spectra. senting the fusion protein was visible and expression reached a maximum 180 min after induction of the culture. The high yield expression in minimal me-Purification of Tat Protein dium enables us to prepare uniformly 13 C-and 15 Nlabeled protein samples for heteronuclear NMR ex-
The fusion of a tag of 10 histidine residues to the Tat sequence allows the rapid purification of the fuperiments which will help to resolve ambiguities in the spectrum due to frequence degeneracy. Espe-sion protein with immobilized metal ion affinity chromatography. Cellular proteins are not or only cially the assignments for the cysteine-rich and arginine-rich basic region might be improved by using weakly bound by the Ni 2/ equilibrated chelating Sepharose column. They can easily be removed by three-dimensional NMR techniques. In addition, la- washing with buffer containing 5 or 100 mM imidaz-applied. This, however, does not result in the preparation of pure Tat protein in a single step, and the ole (Fig. 3) . The fusion protein is strongly bound and elutes at 415 mM imidazole (data not shown). About authors describe the use of two additional columns (MonoS and MonoQ) to obtain Tat free from other 5 mg fusion protein is obtained from 1 g cells. Because the Tat protein contains no internal methio-protein contaminants. Unfortunately, no overall yield is given in the cited reference, and thus a comnine residues, the histidine tag can be removed by cleavage with CNBr. The histidine tag and unclea-parison of the efficiency of the two purification strategies is not possible. ved fusion protein cannot be separated from the Tat protein on a Ni 2/ containing chelating sepharose colThe MonoS column as strong cation exchanger allows the separation of histidine tag, fusion protein, and Tat umn, as it is possible for EIAV Tat (4). This is probably due to the seven cysteine residues anchoring the protein based on their different charge at pH 5.0. We obtained about 1 mg Tat protein from 1 g cells. The purity Tat protein to the column. In fact, a purification scheme for recombinant Tat protein without histi-of full-length monomeric Tat is estimated to be greater than 98% as judged by densitometry of gel bands with dine tag has been introduced by Slice et al. (25) , in which a metal chelate column charged with Zn 2/ is the Cybertech CS-1 system. recovery of Tat after refolding is 18.4 mg with 115 mg fusion protein as starting material. The results of a typical purification are summarized in Table 1 .
Characterization of Recombinant HIV-1 Tat
Before and after cleavage with CNBr, the molecular mass of the fusion protein and the Tat protein, respectively, was determined by MALDI -MS. The molecular mass of the fusion protein is measured to be 12,303 Da compared to 12,626 Da as expected from the amino acid sequence, and the molecular mass of Tat is 10,114 Da which is in excellent agreement with the theoretical value of 10,108 Da (Fig. 4) . MALDI -MS thus confirms that the protein 
Reduction of Disulfide Bonds and Refolding
Before refolding, the seven cysteine residues of Tat are totally reduced with TCEP-HCl which is a stronger reducing agent than dithiothreitol (DTT). TCEP-HCl offers the additional advantage that it cannot form covalent adducts with Tat, whereas covalent adducts with DTT were observed by MALDI-MS (data not shown).
Refolding the diluted protein by stepwise reduction of the urea concentration avoids the formation of aggregates. The fact that no reducing agent is added during the refolding steps results in the formation of two intramolecular disulfide bonds, as judged by Ellman's assay. No structural data on HIV-1 Tat are available concerning the nature of the cysteine residues involved. A comparison with EIAV Tat, however, indicates that one of the disulfide bonds in HIV-1 Tat could be formed between the two cysteine residues in the core domain, i. the proteins are very pure and uniformly monomeric. protein (data not shown). 
